Literature DB >> 5635071

Clinical evaluation of cephaloridine.

N H Steigbigel, J W Kislak, J G Tilles, M Finland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5635071

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  8 in total

1.  Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins.

Authors:  L D Sabath; C Garner; C Wilcox; M Finland
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

2.  Multicentre comparison of cephacetrile and ampicillin in the treatment of urinary tract infections.

Authors:  C Ponticelli; P Zucchelli; G Casucci; I Cervellati; C Dalla Rosa; C Giro; M Motolese
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

Review 3.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1969-07       Impact factor: 2.401

Review 4.  Is it reasonable to use cephalosporins in respiratory and upper tract renal infections in hospitalized patients?

Authors:  R L Perkins
Journal:  Bull N Y Acad Med       Date:  1984-05

5.  Susceptibility of salmonellae to cephalosporins and to nine other antimicrobial agents.

Authors:  R Adams; J D Nelson
Journal:  Appl Microbiol       Date:  1968-10

6.  Cephalexin and cephaloglycin activity in vitro and absorption and urinary excretion of single oral doses in normal young adults.

Authors:  P Braun; J R Tillotson; C Wilcox; M Finland
Journal:  Appl Microbiol       Date:  1968-11

7.  Regression curve analysis of cephalosporin activity.

Authors:  J A Washington; P K Yu
Journal:  Appl Microbiol       Date:  1970-04

8.  Cephacetrile: clinical evaluation in 27 patients.

Authors:  G R Hodges; J F Scholand; R L Perkins
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.